Shandong Intco Medical Products Co Ltd (300677) — Net Asset Quality Index
Shandong Intco Medical Products Co Ltd (300677) has a Net Asset Quality Index of 46.1% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥40.30 Billion minus total liabilities of CN¥21.73 Billion yields net assets of CN¥18.57 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Read how much debt does Shandong Intco Medical Products Co Ltd carry for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Shandong Intco Medical Products Co Ltd Net Asset Quality Index Over Time (2013–2025)
This chart shows how Shandong Intco Medical Products Co Ltd's Net Asset Quality Index has evolved across 13 annual periods from 2013 to 2025. As of March 2026, the index stands at 46.1%, representing net assets of CN¥18.57 Billion against total assets of CN¥40.30 Billion CNY. For live market cap and overall valuation, see 300677 market cap overview.
Annual Net Asset Quality Index for Shandong Intco Medical Products Co Ltd (2013–2025)
The table below presents the year-by-year Net Asset Quality Index for Shandong Intco Medical Products Co Ltd from 2013 to 2025, covering 13 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check Shandong Intco Medical Products Co Ltd PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 46.3% | CN¥18.57 Billion | CN¥40.09 Billion | CN¥21.52 Billion | ▼ -4.7 pp |
| 2024 | 51.1% | CN¥17.68 Billion | CN¥34.63 Billion | CN¥16.95 Billion | ▼ -9.1 pp |
| 2023 | 60.2% | CN¥16.29 Billion | CN¥27.08 Billion | CN¥10.78 Billion | ▼ -14.5 pp |
| 2022 | 74.7% | CN¥16.05 Billion | CN¥21.48 Billion | CN¥5.43 Billion | ▼ -3.5 pp |
| 2021 | 78.2% | CN¥16.12 Billion | CN¥20.62 Billion | CN¥4.50 Billion | ▲ +5.2 pp |
| 2020 | 73.0% | CN¥9.44 Billion | CN¥12.93 Billion | CN¥3.49 Billion | ▲ +22.8 pp |
| 2019 | 50.2% | CN¥1.50 Billion | CN¥2.99 Billion | CN¥1.49 Billion | ▼ -2.3 pp |
| 2018 | 52.5% | CN¥1.27 Billion | CN¥2.42 Billion | CN¥1.15 Billion | ▼ -13.1 pp |
| 2017 | 65.6% | CN¥1.09 Billion | CN¥1.66 Billion | CN¥570.73 Million | ▲ +19.6 pp |
| 2016 | 46.0% | CN¥535.45 Million | CN¥1.16 Billion | CN¥628.30 Million | ▼ -9.0 pp |
| 2015 | 55.1% | CN¥415.19 Million | CN¥754.13 Million | CN¥338.94 Million | ▲ +29.4 pp |
| 2014 | 25.6% | CN¥168.38 Million | CN¥656.54 Million | CN¥488.16 Million | ▲ +4.7 pp |
| 2013 | 21.0% | CN¥147.82 Million | CN¥704.49 Million | CN¥556.67 Million | — |